NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

1Q ‘22 SEC 10Q

BRIEF HILITES:

Ending 3/31/22 CASH $7 mln+ $8 mln (WRT Exercise) = $15 mln Cash (May 6, 2022)

AND

11. Subsequent Events

In total, the Company received $8.3 million from exercises of warrants and issuance of common stock between April 1, 2022 and May 6, 2022.

During April 2022, 7.7 million shares of common stock were issued upon warrant exercises for proceeds of approximately $2.0 million.

During April and May 2022, the Company received $6.3 million from issuance of 8.5 million shares of common stock to various investors. Approximately 1.7 million shares of common stock are pending to be issued.

Quickie: Does not appear to be any new disclosures.

DIFFERENT STROKES for DIFFERENT FOLKS